Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
about
Intracerebral haemorrhage in Down syndrome: protected or predisposed?'Clinical trials in Alzheimer's disease': immunotherapy approachesNeuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapyTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAlzheimer's-related peptide amyloid-β plays a conserved role in angiogenesisTailoring the antibody response to aggregated Aß using novel Alzheimer-vaccinesBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseA coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer's disease model.White matter changes in dementia: role of impaired drainage of interstitial fluid.A vaccine with Aβ oligomer-specific mimotope attenuates cognitive deficits and brain pathologies in transgenic mice with Alzheimer's diseaseInvolvement of Fc receptors in disorders of the central nervous system.Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studiesThe biochemical aftermath of anti-amyloid immunotherapy.Nitric oxide and redox mechanisms in the immune response.Blocking the apolipoprotein E/amyloid-β interaction reduces fibrillar vascular amyloid deposition and cerebral microhemorrhages in TgSwDI mice.Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's diseaseMixed cerebrovascular disease and the future of stroke prevention.A murine model of inflammation-induced cerebral microbleedsAsiatic acid influences parasitaemia reduction and ameliorates malaria anaemia in P. berghei infected Sprague-Dawley male rats.Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse ModelA shift in microglial β-amyloid binding in Alzheimer's disease is associated with cerebral amyloid angiopathy.Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculatureReduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity.Intracranial injection of Gammagard, a human IVIg, modulates the inflammatory response of the brain and lowers Aβ in APP/PS1 mice along a different time course than anti-Aβ antibodies.Vascular cognitive impairment and dementia.Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?Gantenerumab for the treatment of Alzheimer's disease.Regulatory Forum Opinion Piece*: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry Survey.Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models.Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice.Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction.A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?Proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems.The association between vertebrobasilar insufficiency and the risk of dementia: a nationwide register-based retrospective cohort study in Taiwan.
P2860
Q26745369-C04B539D-942F-49F5-9639-2950A483616CQ27008979-202781E7-10DB-44D4-813D-F920F08DB21AQ27014919-B7C0C3B5-F87A-49AB-94DA-8F2882837779Q27021700-B5871D23-77D1-48FB-BBFE-542C9711A363Q27300765-2AA8C0AC-095A-445D-9949-E2FCC01636DBQ27320084-613BC19C-90E5-4200-ADC0-85D84339F144Q28259585-1BA4009C-EFAE-4B7E-8123-24295507CEE8Q30581976-68C0CFC3-76E4-4E11-B164-4C0DE16D5B87Q30880445-05A89CCE-C796-4DD8-8DD8-01B879DC962BQ33771800-DCFEC34B-560A-414E-80A8-F86C2C1A0952Q33886574-449B4217-3E7C-4915-A18D-5E93201D9406Q33969633-2A31A22D-1BCC-4A56-8821-0B207247F8AFQ33999537-E20CB9FC-915D-477F-A278-35BE9ABE77C0Q34219001-A557D6FC-F3E4-466C-92BD-1F7D9EF0524FQ34221510-0FFF83B8-AC9E-4CA9-8288-40E2714A2D8FQ35001939-75742789-F62D-4586-9B9C-71E71DB24F97Q35095392-B6733B62-69FB-4750-A7D3-4E78F397898DQ35240865-5B3FF17F-0C45-4203-9155-B1383BC4B491Q35997824-DF7973CD-E456-4292-90A8-66C8CF106993Q36025087-E7CF4341-47FD-4737-90E3-24A12C7789B1Q36117715-651BA1FF-B322-469A-84A0-80F5066D4279Q36130291-FF32B70F-1758-4A68-9D9B-37AF266A84EBQ36576263-BE16E371-4909-404B-8816-8AD7C7D80A92Q36652260-5767BB16-85F3-482D-82A8-70AD7CF867AAQ37130346-5A9FC2BE-7778-49F9-AB45-AB4F4EF1B810Q37270930-D8300B3C-D471-4C22-9D09-D987DC92075DQ37340312-96A19A8E-2479-4BFA-B9CF-BEE2E2FF9546Q37583350-9F36C3FC-3300-41C7-B248-83978E71F047Q37630548-7BEE7819-0BFC-480A-BCF7-CC6BF3F427CEQ37698598-1BC0332E-3EF4-46D2-A00D-E27E43FD2CDCQ38009878-C9490A25-25E5-486B-B482-401D9674B65AQ38870693-577ACD4A-5727-4BF0-A077-F1907094EBBDQ38910326-B685BED9-F4E1-498E-8AE5-F294BEAB7EC6Q41700187-8AB98065-31D9-4783-B8C2-FBBF277FB359Q41843995-23E9D477-963D-41B9-8504-86C481874DABQ42325913-9C9EBAA5-566E-45DB-AC97-4E9B8DAE2BD1Q43161399-7554ACF6-76F1-4ECE-862D-85694F00D12CQ45732217-FF9D246A-5538-4DA6-A73F-3942D8C2CE70Q46161445-F6760D97-5372-4EC2-9B8D-322D6D451C46Q47110794-6DF59809-D259-4134-8271-883A4664B434
P2860
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@en
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@nl
type
label
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@en
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@nl
prefLabel
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@en
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@nl
P2860
P1476
Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.
@en
P2093
Donna M Wilcock
P2860
P356
10.2174/187152709787601858
P577
2009-03-01T00:00:00Z